Perioperative ECG spectrum changes of anxiety breast cancer patients and treatment effect of small dose midazolam

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200065797

Enrollment

Unknown

Registered

2022-11-15

Start date

2022-12-01

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative anxiety

Interventions

Midazolam group:Intravenous midazolam before induction

Control group:Intravenous saline before induction

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 75 years; 2. Females, ASA classification I-III ; 3. Able to communicate.

Exclusion criteria

Exclusion criteria: 1. Allergic to midazolam; 2. History of neuropsychiatric system; 3. Have been included in other clinical studies.

Design outcomes

Primary

Measure	Time frame
Anxiety scale score;ECG changes;	—

Secondary

Measure	Time frame
PSi index;Visual analogue scale score for pain;	—

Countries

China

Contacts

Public ContactZheng Kang

Southease University Zhongda Hospital

robertzheng@163.com+86 13327819101

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026